• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性胰腺炎作为胰腺癌的驱动因素:流行病学认识

Chronic pancreatitis as a driving factor for pancreatic cancer: An epidemiological understanding.

作者信息

Das Amlan, Bararia Akash, Mukherjee Sanghamitra, Sikdar Nilabja

机构信息

Department of Biochemistry, Royal Global University, Guwahati 781035, India.

Human Genetics Unit, Indian Statistical Institute, Kolkata 700108, India.

出版信息

World J Clin Oncol. 2024 Dec 24;15(12):1459-1462. doi: 10.5306/wjco.v15.i12.1459.

DOI:10.5306/wjco.v15.i12.1459
PMID:39720649
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11514376/
Abstract

The retrospective study by Lew (2022) examined the rising hospitalization rates for chronic pancreatitis (CP) and its association with pancreatic ductal adenocarcinoma (PDAC), revealing significant ethno-racial disparities and risk factors. Overweight black men aged 40-59 years and white men over 40 years with higher incomes showed an elevated risk of PDAC among CP patients. The study, which included 14.2 million admissions from 2016-2017, found that 2.6% of adult patients were diagnosed with CP, with white males being the majority. Multivariate regression analysis identified men, black individuals, those aged 40-59 years, and individuals with a body mass index (BMI) between 25 and 29.9 as having an increased risk for CP. Moreover, 0.78% of CP patients also had PDAC, with older age and BMI being significant risk factors for developing PDAC in CP patients. The study also highlighted disparities in healthcare access and utilization among different socioeconomic and ethno-racial groups, which may impact the risk and outcomes of CP and PDAC.

摘要

Lew(2022年)的回顾性研究调查了慢性胰腺炎(CP)住院率的上升及其与胰腺导管腺癌(PDAC)的关联,揭示了显著的种族差异和风险因素。40至59岁的超重黑人男性以及40岁以上收入较高的白人男性在CP患者中患PDAC的风险升高。该研究纳入了2016年至2017年的1420万例住院病例,发现2.6%的成年患者被诊断为CP,其中白人男性占多数。多变量回归分析确定男性、黑人、40至59岁的人群以及体重指数(BMI)在25至29.9之间的个体患CP的风险增加。此外,0.78%的CP患者也患有PDAC,年龄较大和BMI是CP患者发生PDAC的重要风险因素。该研究还强调了不同社会经济和种族群体在医疗保健获取和利用方面的差异,这可能会影响CP和PDAC的风险及治疗结果。

相似文献

1
Chronic pancreatitis as a driving factor for pancreatic cancer: An epidemiological understanding.慢性胰腺炎作为胰腺癌的驱动因素:流行病学认识
World J Clin Oncol. 2024 Dec 24;15(12):1459-1462. doi: 10.5306/wjco.v15.i12.1459.
2
Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the United States.美国慢性胰腺炎和胰腺导管腺癌住院患者的流行病学危险因素。
World J Clin Oncol. 2022 Nov 24;13(11):907-917. doi: 10.5306/wjco.v13.i11.907.
3
Risk of Developing Pancreatic Cancer in Patients with Chronic Pancreatitis.慢性胰腺炎患者患胰腺癌的风险
J Clin Med. 2020 Nov 19;9(11):3720. doi: 10.3390/jcm9113720.
4
Chronic Pancreatitis Is a Risk Factor for Pancreatic Cancer, and Incidence Increases With Duration of Disease: A Systematic Review and Meta-analysis.慢性胰腺炎是胰腺癌的一个危险因素,其发病率随着疾病持续时间的延长而增加:系统评价和荟萃分析。
Clin Transl Gastroenterol. 2022 Mar 28;13(3):e00463. doi: 10.14309/ctg.0000000000000463.
5
Incidence and Risk of Pancreatic Cancer in Patients with a New Diagnosis of Chronic Pancreatitis.慢性胰腺炎初诊患者罹患胰腺癌的发病率和风险。
Dig Dis Sci. 2022 Feb;67(2):708-715. doi: 10.1007/s10620-021-06886-7. Epub 2021 Feb 25.
6
Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.比较慢性胰腺炎和胰腺导管腺癌中基质细胞和导管上皮细胞的特征。
PLoS One. 2014 May 5;9(5):e94357. doi: 10.1371/journal.pone.0094357. eCollection 2014.
7
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.胰腺癌和慢性胰腺炎是否具有相同的遗传风险因素?一项胰腺癌疾病研究(PANDoRA)联盟调查。
Int J Cancer. 2018 Jan 15;142(2):290-296. doi: 10.1002/ijc.31047. Epub 2017 Oct 16.
8
Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.用于区分自身免疫性胰腺炎、慢性胰腺炎和胰腺导管腺癌的不同病理生理细胞因子谱。
J Transl Med. 2017 Jun 2;15(1):126. doi: 10.1186/s12967-017-1227-3.
9
Two nomograms for differentiating mass-forming chronic pancreatitis from pancreatic ductal adenocarcinoma in patients with chronic pancreatitis.两种列线图用于区分慢性胰腺炎患者的肿块型慢性胰腺炎和胰腺导管腺癌。
Eur Radiol. 2022 Sep;32(9):6336-6347. doi: 10.1007/s00330-022-08698-3. Epub 2022 Apr 8.
10
Association between chronic pancreatitis and pancreatic cancer: A 10-year retrospective study of endoscopically treated and surgical patients.慢性胰腺炎与胰腺癌的相关性:一项对内镜治疗和手术治疗患者进行的 10 年回顾性研究。
Int J Cancer. 2020 Sep 1;147(5):1450-1460. doi: 10.1002/ijc.32971. Epub 2020 Apr 3.

引用本文的文献

1
Early Detection of Pancreatic Cancer: Current Advances and Future Opportunities.胰腺癌的早期检测:当前进展与未来机遇
Biomedicines. 2025 Jul 15;13(7):1733. doi: 10.3390/biomedicines13071733.
2
Diagnostic performance of artificial intelligence based on contrast-enhanced computed tomography in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.基于对比增强计算机断层扫描的人工智能在胰腺导管腺癌中的诊断性能:一项系统评价和荟萃分析。
Abdom Radiol (NY). 2025 Jul 2. doi: 10.1007/s00261-025-05089-2.

本文引用的文献

1
Incidence and risk of pancreatic cancer in patients with acute or chronic pancreatitis: a population-based cohort study.急性或慢性胰腺炎患者胰腺癌的发病率和风险:一项基于人群的队列研究。
Sci Rep. 2023 Nov 2;13(1):18930. doi: 10.1038/s41598-023-45382-y.
2
Pancreatitis and Pancreatic Cancer Risk.胰腺炎与胰腺癌风险。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231164875. doi: 10.1177/15330338231164875.
3
Incidence and risk of pancreatic cancer in patients with chronic pancreatitis: defining the optimal subgroup for surveillance.慢性胰腺炎患者胰腺癌的发病率和风险:确定监测的最佳亚组。
Sci Rep. 2023 Jan 3;13(1):106. doi: 10.1038/s41598-022-26411-8.
4
Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the United States.美国慢性胰腺炎和胰腺导管腺癌住院患者的流行病学危险因素。
World J Clin Oncol. 2022 Nov 24;13(11):907-917. doi: 10.5306/wjco.v13.i11.907.
5
Chronic pancreatitis and cancer risk in a matched cohort study using national claims data in South Korea.韩国国家理赔数据匹配队列研究中慢性胰腺炎与癌症风险
Sci Rep. 2022 Apr 1;12(1):5545. doi: 10.1038/s41598-022-09426-z.
6
Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models.胰腺癌的基因突变与基因工程小鼠模型
Cancers (Basel). 2021 Dec 24;14(1):71. doi: 10.3390/cancers14010071.
7
Genomic analyses identify molecular subtypes of pancreatic cancer.基因组分析确定了胰腺癌的分子亚型。
Nature. 2016 Mar 3;531(7592):47-52. doi: 10.1038/nature16965. Epub 2016 Feb 24.
8
Cell intrinsic role of COX-2 in pancreatic cancer development.COX-2 在胰腺癌发生发展中的细胞内固有作用。
Mol Cancer Ther. 2012 Oct;11(10):2127-37. doi: 10.1158/1535-7163.MCT-12-0342. Epub 2012 Jul 10.
9
What we have learned about pancreatic cancer from mouse models.我们从小鼠模型中了解到的关于胰腺癌的知识。
Gastroenterology. 2012 May;142(5):1079-92. doi: 10.1053/j.gastro.2012.03.002. Epub 2012 Mar 8.
10
Pancreatitis and pancreatic cancer: a population-based study.胰腺炎与胰腺癌:一项基于人群的研究。
J Natl Cancer Inst. 1994 Apr 20;86(8):625-7. doi: 10.1093/jnci/86.8.625.